APREA
Aprea is a biotech company focusing on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53. The Company's lead program, APR-246, is a first-in-class small molecule drug candidate in clinical development. Aprea Therapeutics was established in 2003 in Stockholms Lan, Sweden by Klas Wiman and Galina Selivanova.
APREA
Industry:
Biotechnology Health Care Medical Personal Health Pharmaceutical
Founded:
2003-01-01
Address:
Stockholm, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.aprea.com
Total Employee:
1+
Status:
Active
Contact:
+460850884504
Email Addresses:
[email protected]
Total Funding:
136.37 M USD
Technology used in webpage:
Domain Not Resolving Apple Mobile Web Clips Icon Content Delivery Network JsDelivr Nginx COVID-19 Gravity Forms Akamai Hosted Nginx 1.10 Formidable Pro Form
Similar Organizations
AEON Biopharma
AEON Biopharma is a biopharmaceutical company that develops novel and proprietary treatment paradigms to improve patient outcomes.
AstraZeneca
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines.
Cellectis
Cellectis is a biopharmaceutical company that develops adoptive immunotherapies for cancer.
CStone Pharmaceuticals
CStone Pharmaceuticals is a bio-pharmaceutical company develops new treatments in a range of therapeutic areas.
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
Medivir
Medivir is a research-based pharmaceutical company with a research focus on oncology and infectious diseases.
Novartis
Novartis is a healthcare company that provides solutions to address the evolving needs of patients worldwide.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Sprout Pharmaceuticals
Sprout Pharmaceuticals is a medical company that develops products for the treatment of female sexual dysfunction.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-05-16 | Atrin Pharmaceuticals | Atrin Pharmaceuticals acquired by Aprea | N/A |
Investors List
Dafna Capital Management
Dafna Capital Management investment in Post-IPO Equity - Aprea
Nantahala Capital Management
Nantahala Capital Management investment in Post-IPO Equity - Aprea
Sphera Global Healthcare Fund
Sphera Global Healthcare Fund investment in Post-IPO Equity - Aprea
Exome Asset Management
Exome Asset Management investment in Post-IPO Equity - Aprea
Stonepine Capital Management
Stonepine Capital Management investment in Post-IPO Equity - Aprea
National Cancer Institute
National Cancer Institute investment in Grant - Aprea
Keiretsu Capital
Keiretsu Capital investment in Post-IPO Equity - Aprea
Janus Henderson Investors
Janus Henderson Investors investment in Series C - Aprea
Redmile Group
Redmile Group investment in Series C - Aprea
Karolinska
Karolinska investment in Series C - Aprea
Official Site Inspections
http://www.aprea.com Semrush global rank: 5.01 M Semrush visits lastest month: 1.65 K
- Host name: 172.67.162.53
- IP address: 172.67.162.53
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Aprea"
Home - Asia Pacific Real Assets Association
The Asia Pacific Real Assets Leaders’ Congress is APREA’s flagship event and the centerpiece of its 20th anniversary celebration.See details»
Aprea Therapeutics | Leaders in DDR-Targeted Solutions
Aprea’s executive management team, Board of Directors and scientific founders are unified by their dedication to developing groundbreaking, precision therapeutics for patients with …See details»
Apria Home Medical Equipment and Support For Sleep Apnea, …
Apria is a leading US provider of home medical equipment delivery and clinical support, with services for COPD, sleep apnea, wound therapy, and more.See details»
Aprea - Crunchbase Company Profile & Funding
Aprea is a biotech company focusing on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53. The …See details»
Aprea - Profiles & Contacts - Crunchbase
Aprea is a biopharmaceutical company that develops novel cancer therapeutics.See details»
What We Do - Aprea Therapeutics
And we continue to forge new paths. Today, Aprea Therapeutics is a clinical-stage biotechnology company focused on the development of novel, synthetic lethality-based therapies with direct …See details»
Aprea Therapeutics Board of Directors
Meet the Aprea Therapeutics board of directors. Their exceptional qualifications and expertise have fueled our growth as leaders in DDR-targeted therapeutics.See details»
Aprea - News & Analysis - Crunchbase
Mar 26, 2025 Aprea is a biopharmaceutical company that develops novel cancer therapeutics.See details»
Aprea Therapeutics Pipeline
The Aprea Therapeutics pipeline is focused on increasing the specificity and reducing the toxicity of DDR Inhibitors, giving patients more options.See details»
Lobbying Firm | Aprea & Company | California
Aprea & Company represents a wide variety of clients including Fortune 100 companies, national and statewide trade associations, public agencies, and nonprofits. We have had the privilege …See details»
APREA Team - Asia Pacific Real Assets Association
Sigrid is the Chief Executive Officer of Asia Pacific Real Assets Association (APREA). Based in Singapore, she is responsible for overseeing the strategic direction, initiatives and operations …See details»
Aprea Therapeutics - businessabc
4 days ago Aprea Therapeutics was founded in 2008 with a mission to develop anticancer compounds that specifically target tumor suppressing proteins. The company has since …See details»
APREA Members - Asia Pacific Real Assets Association
Real Assets TV Real Assets, Real People APREA Members Get in touch with APREA Learn more about the ins and outs of the Asia-Pacific real assets scene CONTACT US APREA strives to …See details»
Login - Apria
SIGN IN New to Apria PAP Portal? Register today Forgot Password? Send me a link to reset my password New to Apria? Please call us at 1-877-265-2426. For Kaiser Permanente members …See details»
Sexual Abuse Healing and Prevention Resources | Saprea
Saprea (formerly The Younique Foundation and Defend Innocence) is a nonprofit that provides resources to prevent and heal from sexual abuse.See details»
Aprea Therapeutics Launches New Corporate Website
BOSTON, April 06, 2020 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing novel cancer …See details»
Membership - Asia Pacific Real Assets Association - aprea.asia
APREA strives to be the leading advocate for the real assets sector in Asia Pacific. Asia Pacific Real Assets Association Limited 18 Robinson Road #15-01, Singapore 048547 Tel: +65 6955 …See details»
Aprea Therapeutics Announces Strategic IP Portfolio Evolution in …
DOYLESTOWN, Pa., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company developing …See details»
Management Team - Aprea Therapeutics
Meet the Aprea Therapeutics management team of world-class precision oncology leaders who are developing groundbreaking DDR-targeted therapeutics.See details»
Aprea - Funding, Financials, Valuation & Investors - Crunchbase
Aprea has acquired Atrin Pharmaceuticals on May 16, 2022. Which types of acquisition does this organization make most frequently?See details»